Reportlinker Adds North America Anesthesia and Respiratory Devices Investment Opportunities, Analysis and Forecasts to 2015
* Reuters is not responsible for the content in this press release.
NEW YORK--(Business Wire)-- Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds North America Anesthesia and Respiratory Devices Investment Opportunities, Analysis and Forecasts to 2015 http://www.reportlinker.com/p0128616/Reportlinker-Adds-North-America-Anesthesia-and-Respiratory-Devices-Investment-Opportunities-Analysis-and-Forecasts-to-2015.html North America Anesthesia and Respiratory Devices Investment Opportunities, Analysis and Forecasts to 2015 Summary This report is an essential source for in-depth information and data relating to North America anesthesia and respiratory devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the anesthesia and respiratory devices in North America Scope - The report provides anesthesia and respiratory devices information broken down into detailed categories in North America. - Total revenues, products sold and end users. - Market shares of all the key competitors. - Key pipeline products that are set to shape the market, broken down by sector. - Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information. - Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement. - Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes. - Key mergers and acquisitions, partnerships, private equity investments and IPOs. - Customer, hospitals and physicians data. Reasons to buy - Gain a strong understanding of the anesthesia and respiratory devices market in North America. - Evaluate and compare the attractiveness of the market in the region. - Identify growth segments and opportunities in each industry sector within the region. - Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the region. - Analyze the competitiveness of the market in the region and identify hotspots. - Develop strategies based on the latest product, brand, expansion and research and development news in the region. - Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the region. - Identify and analyze the strengths and weaknesses of the industry incumbents in the region. 1 Table of Contents 1 Table of Contents 2 1.1 List of Tables 13 1.2 List of Figures 17 2 Introduction 18 2.1 What Is This Report About? 18 3 Definitions of the Markets Covered in the Report 19 3.1 Anesthesia and Respiratory Devices 19 3.2 Anesthesia Disposables 19 3.3 Anesthesia Machines 19 3.4 Respiratory Devices 19 3.5 Respiratory Disposables 19 3.6 Respiratory Measurement Devices 19 3.7 Sleep Apnea Diagnostic Systems 19 4 Anesthesia and Respiratory Devices in North America 20 4.1 Anesthesia and Respiratory Devices, North America, Overall Revenue ($ mn), 2000-2015 20 4.2 Anesthesia and Respiratory Devices, North America, Category Volume (Units), 2000-2015 25 4.3 Anesthesia and Respiratory Devices, North America, Company share (2007-2008) 28 5 Anesthesia and Respiratory Devices In United States 29 5.1 Anesthesia and Respiratory Devices, United States, Overall Revenue ($ mn), 2000-2015 29 5.2 Anesthesia and Respiratory Devices, United States, Category Volume (Units), 2000-2015 34 5.3 Anesthesia and Respiratory Devices, United States, Distribution Share (2006-2007) 37 5.3.1 Anesthesia Disposables Distribution Share (2006-2007) 37 5.3.2 Anesthesia Machines Distribution Share (2007-2008) 37 5.3.3 Respiratory Devices Distribution Share (2006-2007) 38 5.3.4 Respiratory Disposables Distribution Share (2007-2008) 38 5.3.5 Respiratory Measurement Devices Distribution Share (2007-2008) 39 5.3.6 Sleep Apnea Diagnostic Systems Distribution Share (2007-2008) 39 5.4 Anesthesia and Respiratory Devices, United States, Company Share (2007-2008) 40 5.4.1 Anesthesia and Respiratory Devices, United States, Company Share (2007-2008) 40 5.4.2 Anesthesia Disposables, United States, Company Share (2007-2008) 41 5.4.3 Anesthesia Machines, United States, Company Share (2007-2008) 42 5.4.4 Respiratory Devices, United States, Company Share (2007-2008) 43 5.4.5 Respiratory Disposables, United States, Company Share (2007-2008) 44 5.4.6 Respiratory Measurement Devices, United States, Company Share (2007-2008) 45 5.4.7 Sleep Apnea Diagnostic Systems, United States, Company Share (2007-2008) 46 6 Anesthesia and Respiratory Devices In Canada 47 6.1 Anesthesia and Respiratory Devices, Canada, Overall Revenue ($ mn), 2000-2015 47 6.2 Anesthesia and Respiratory Devices, Canada, Category Volume (Units), 2000-2015 50 6.3 Anesthesia and Respiratory Devices, Canada, Distribution Share (2006-2007) 52 6.3.1 Anesthesia Disposables Distribution Share (2007-2008) 52 6.3.2 Anesthesia Machines Distribution Share (2007-2008) 52 6.3.3 Respiratory Devices Distribution Share (2007-2008) 53 6.3.4 Respiratory Disposables Distribution Share (2007-2008) 53 6.3.5 Respiratory Measurement Devices Distribution Share (2007-2008) 54 6.3.6 Sleep Apnea Diagnostic Systems Distribution Share (2007-2008) 54 6.4 Anesthesia and Respiratory Devices, Canada, Company Share (2007-2008) 55 6.4.1 Anesthesia and Respiratory Devices, Canada Company Share (2007-2008) 55 6.4.2 Anesthesia Disposables, Canada, Company Share (2007-2008) 56 6.4.3 Anesthesia Machines, Canada, Company Share (2007-2008) 57 6.4.4 Respiratory Devices, Canada, Company Share (2007-2008) 58 6.4.5 Respiratory Disposables, Canada, Company Share (2007-2008) 59 6.4.6 Respiratory Measurement Devices, Canada, Company Share (2007-2008) 60 6.4.7 Sleep Apnea Diagnostic Systems, Canada, Company Share (2007-2008) 61 7 Overview of Key Companies in North America Anesthesia and Respiratory Devices Market 62 7.1 Philips Healthcare 62 7.1.1 Company Overview 62 7.1.2 Value Chain Analysis 63 7.1.2.1 Manufacturing 63 7.1.2.2 Product Development 64 7.1.2.3 Sales and Marketing 64 7.2 ResMed Inc. 66 7.2.1 Company Overview 66 7.2.2 Value Chain Analysis 66 7.2.2.1 Manufacturing 67 7.2.2.2 Product Development 67 7.2.2.3 Sales and Marketing 68 7.2.3 ResMed Inc. Pipeline Products 69 7.2.3.1 ResMed Inc. Pipeline Products By Equipment Type 69 7.2.3.2 ResMed Inc. Pipeline Products By Development Stage 69 7.2.3.3 ResMed Inc. Pipeline Products By Therapy Area 69 7.2.3.4 ResMed Inc. Pipeline Products By Clinical Trials 69 7.3 GE Healthcare 70 7.3.1 Company Overview 70 7.4 Smiths Medical Company Profile 71 7.4.1 Company Overview 71 7.4.2 Value Chain Analysis 72 7.4.2.1 Manufacturing 72 7.4.2.2 Product Development 72 7.4.2.3 Sales and Marketing 73 7.5 Covidien Ltd. 74 7.5.1 Company Overview 74 7.5.2 Value Chain Analysis 75 7.5.2.1 Manufacturing 75 7.5.2.2 Product Development 75 7.5.2.3 Sales and Marketing 76 7.5.3 Covidien Ltd./Tyco Healthcare Pipeline Products 77 7.5.3.1 Covidien Ltd./Tyco Healthcare Pipeline Products By Equipment Type 77 7.5.3.2 Covidien Ltd./Tyco Healthcare Pipeline Products By Development Stage 77 7.5.3.3 Covidien Ltd./Tyco Healthcare Pipeline Products By Therapy Area 77 7.5.3.4 Covidien Ltd./Tyco Healthcare Pipeline Products By Clinical Trials 77 7.5.3.5 Covidien Ltd./Tyco Healthcare Pipeline Products By News Summary 77 7.6 Cardinal Health, Inc. 78 7.6.1 Company Overview 78 7.6.2 Value Chain Analysis 78 7.6.2.1 Manufacturing 79 7.6.2.2 Product Development 79 7.6.2.3 Sales and Marketing 80 7.7 A G Industries 81 7.7.1 Company Overview 81 7.8 Abundant Home Care 81 7.8.1 Company Overview 81 7.9 Advanced Brain Monitoring, Inc. 81 7.9.1 Company Overview 81 7.9.2 Advanced Brain Monitoring, Inc. Pipeline Products By Equipment Type 82 7.9.3 Advanced Brain Monitoring, Inc. Pipeline Products By Development Stage 82 7.9.4 Advanced Brain Monitoring, Inc. Pipeline Products By Therapy Area 82 7.9.5 Advanced Brain Monitoring, Inc. Pipeline Products By Clinical Trials 82 7.10 Alliance Oxygen 83 7.10.1 Company Overview 83 7.11 Amvex Corporation 83 7.11.1 Company Overview 83 7.12 Anestec Inc. 83 7.12.1 Company Overview 83 7.13 Afton Medical, LLC 83 7.13.1 Company Overview 83 7.14 AG Industries 84 7.14.1 Company Overview 84 7.15 Airon Corporation 84 7.15.1 Company Overview 84 7.16 AirSep Corporation 84 7.16.1 Company Overview 84 7.17 Alliance Tech Medical, Inc. 84 7.17.1 Company Overview 84 7.18 Allied Healthcare Products, Inc. 85 7.18.1 Company Overview 85 7.19 ALung Technologies, Inc. 86 7.19.1 Company Overview 86 7.19.2 ALung Technologies, Inc. Pipeline Products 86 7.19.2.1 ALung Technologies, Inc. Pipeline Products By Equipment Type 86 7.19.2.2 ALung Technologies, Inc. Pipeline Products By Development Stage 86 7.19.2.3 ALung Technologies, Inc. Pipeline Products By Therapy Area 86 7.19.2.4 ALung Technologies, Inc. Pipeline Products By Clinical Trials 87 7.20 Apneon, Inc. 88 7.20.1 Company Overview 88 7.20.2 Apneon, Inc. Pipeline Products 88 7.20.2.1 Apneon, Inc. Pipeline Products By Equipment Type 88 7.20.2.2 Apneon, Inc. Pipeline Products By Development Stage 88 7.20.2.3 Apneon, Inc. Pipeline Products By Therapy Area 88 7.21 Aspire Medical, Inc. 89 7.21.1 Company Overview 89 7.21.2 Aspire Medical, Inc. Pipeline Products 89 7.21.2.1 Aspire Medical, Inc. Pipeline Products By Equipment Type 89 7.21.2.2 Aspire Medical, Inc. Pipeline Products By Development Stage 89 7.21.2.3 Aspire Medical, Inc. Pipeline Products By Therapy Area 89 7.21.2.4 Aspire Medical, Inc. Pipeline Products By Clinical Trials 89 7.21.2.5 Aspire Medical, Inc. Pipeline Products By News Summary 89 7.22 Asthmatx Inc. 90 7.22.1 Company Overview 90 7.22.2 Asthmatx Inc. Pipeline Products 90 7.22.2.1 Asthmatx Inc. Pipeline Products By Equipment Type 90 7.22.2.2 Asthmatx Inc. Pipeline Products By Development Stage 90 7.22.2.3 Asthmatx Inc. Pipeline Products By Therapy Area 90 7.22.2.4 Asthmatx Inc. Pipeline Products By Clinical Trials 90 7.22.2.5 Asthmatx Inc. Pipeline Products By News Summary 90 7.23 Brandon Biomed Inc. 91 7.23.1 Company Overview 91 7.24 Broncus Technologies, Inc. 92 7.24.1 Company Overview 92 7.24.2 Broncus Technologies, Inc. Pipeline Products 92 7.24.2.1 Broncus Technologies, Inc. Pipeline Products By Equipment Type 92 7.24.2.2 Broncus Technologies, Inc. Pipeline Products By Development Stage 92 7.24.2.3 Broncus Technologies, Inc. Pipeline Products By Therapy Area 92 7.24.2.4 Broncus Technologies, Inc. Pipeline Products By Clinical Trials 92 7.24.2.5 Broncus Technologies, Inc. Pipeline Products By News Summary 93 7.25 BOMImed Inc. 94 7.25.1 Company Overview 94 7.26 Cpr Medical Devices Inc 94 7.26.1 Company Overview 94 7.27 CAIRE, Inc. 94 7.27.1 Company Overview 94 7.28 CardioPulmonary Technologies, Inc. 94 7.28.1 Company Overview 94 7.29 CHAD Therapeutics, Inc. 95 7.29.1 Company Overview 95 7.30 DeVilbiss Healthcare 95 7.30.1 Company Overview 95 7.31 Electromed, Inc. 95 7.31.1 Company Overview 95 7.32 Elixair Medical, Inc. 95 7.32.1 Company Overview 95 7.33 Embla Systems 96 7.33.1 Company Overview 96 7.33.2 Embla Systems Pipeline Products 96 7.33.2.1 Embla Systems Pipeline Products By Equipment Type 96 7.33.2.2 Embla Systems Pipeline Products By Development Stage 96 7.34 Emergency Filtration Products, Inc. 97 7.34.1 Company Overview 97 7.35 Emergent Respiratory Products, Inc. 97 7.35.1 Company Overview 97 7.36 Emphasys Medical, Inc. 98 7.36.1 Company Overview 98 7.36.2 Emphasys Medical, Inc. Pipeline Products 98 7.36.2.1 Emphasys Medical, Inc. Pipeline Products By Equipment Type 98 7.36.2.2 Emphasys Medical, Inc. Pipeline Products By Development Stage 98 7.36.2.3 Emphasys Medical, Inc. Pipeline Products By Therapy Area 98 7.36.2.4 Emphasys Medical, Inc. Pipeline Products By Clinical Trials 99 7.36.2.5 Emphasys Medical, Inc. Pipeline Products By News Summary 99 7.37 eVent Medical, Inc. 99 7.37.1 Company Overview 99 7.38 Inogen, Inc. 100 7.38.1 Company Overview 100 7.39 Nanomix, Inc. 100 7.39.1 Company Overview 100 7.39.2 Nanomix, Inc. Pipeline Products 100 7.39.2.1 Nanomix, Inc. Pipeline Products By Equipment Type 100 7.39.2.2 Nanomix, Inc. Pipeline Products By Development Stage 100 7.39.2.3 Nanomix, Inc. Pipeline Products By Therapy Area 100 7.40 Ornim, Inc. 101 7.40.1 Company Overview 101 7.40.2 Ornim, Inc. Pipeline Products 101 7.40.2.1 Ornim, Inc. Pipeline Products By Equipment Type 101 7.40.2.2 Ornim, Inc. Pipeline Products By Development Stage 101 7.40.2.3 Ornim, Inc. Pipeline Products By Therapy Area 101 7.40.2.4 Ornim, Inc. Pipeline Products By News Summary 101 7.41 OSI Systems, Inc. 102 7.41.1 Company Overview 102 7.41.2 Value Chain Analysis 102 7.41.2.1 Manufacturing 103 7.41.2.2 Product Development 103 7.41.2.3 Sales and Marketing 103 7.42 PARI Respiratory Equipment, Inc. 104 7.42.1 Company Overview 104 7.42.2 PARI Respiratory Equipment, Inc. Pipeline Products 104 7.42.2.1 PARI Respiratory Equipment, Inc. Pipeline Products By Equipment Type 104 7.42.2.2 PARI Respiratory Equipment, Inc. Pipeline Products By Development Stage 104 7.42.2.3 PARI Respiratory Equipment, Inc. Pipeline Products By Therapy Area 104 7.42.2.4 PARI Respiratory Equipment, Inc. Pipeline Products By Clinical Trials 104 7.43 Pulmonx Corporation 105 7.43.1 Company Overview 105 7.43.2 Pulmonx Corporation Pipeline Products 105 7.43.2.1 Pulmonx Corporation Pipeline Products By Equipment Type 105 7.43.2.2 Pulmonx Corporation Pipeline Products By Development Stage 105 7.43.2.3 Pulmonx Corporation Pipeline Products By Therapy Area 105 7.43.2.4 Pulmonx Corporation Pipeline Products By Clinical Trials 105 7.44 Respironics, Inc. 106 7.44.1 Company Overview 106 7.44.2 Value Chain Analysis 107 7.44.2.1 Manufacturing 107 7.44.2.2 Product Development 107 7.44.2.3 Sales and Marketing 108 7.45 SPO Medical Inc. 109 7.45.1 Company Overview 109 7.45.2 SPO Medical Inc. Pipeline Products 109 7.45.2.1 SPO Medical Inc. Pipeline Products By Equipment Type 109 7.45.2.2 SPO Medical Inc. Pipeline Products By Development Stage 109 7.45.2.3 SPO Medical Inc. Pipeline Products By Therapy Area 109 7.46 Vital Signs, Inc. 110 7.46.1 Company Overview 110 7.47 King Systems Corporation 110 7.47.1 Company Overview 110 7.48 Teleflex Incorporated 111 7.48.1 Company Overview 111 7.48.2 Value Chain Analysis 112 7.48.2.1 Manufacturing 112 7.48.2.2 Product Development 113 7.48.2.3 Sales and Marketing 113 7.49 MAQUET GmbH & Co. KG 114 7.49.1 Company Overview 114 7.50 O-TWO MEDICAL TECHNOLOGIES INC. 114 7.50.1 Company Overview 114 7.51 Roxon Medi-Tech Ltd. 114 7.51.1 Company Overview 114 7.52 Draegerwerk Aktiengesellschaft 115 7.52.1 Company Overview 115 7.52.2 Value Chain Analysis 116 7.52.2.1 Manufacturing 116 7.52.2.2 Product Development 117 7.52.2.3 Sales and Marketing 117 7.52.3 Drager Medical AG & Co. KG Pipeline Products 118 7.52.3.1 Drager Medical AG & Co. KG Pipeline Products By Equipment Type 118 7.52.3.2 Drager Medical AG & Co. KG Pipeline Products By Development Stage 118 7.52.3.3 Drager Medical AG & Co. KG Pipeline Products By Therapy Area 118 8 Financial Deals Landscape 119 8.1 Acquisition 119 8.1.1 Nicholas Piramal India Acquires MINRAD INTERNATIONAL 119 8.1.2 Applied Nanoscience Terminates Acquisition Of Emergency Filtration Products 121 8.1.3 Arkema Acquires Oxford Performance Materials 122 8.1.4 Nihon Kohden Acquires Neurotronics 123 8.1.5 MBF Healthcare Terminates Acquisition Of Critical Homecare Soluitons From Kohlberg & Co 124 8.1.6 GE Healthcare Acquires Vital Signs 125 8.1.7 Linde North America Acquires Respiratory Support Services 127 8.1.8 Medtronic Acquires Restore Medical 128 8.1.9 Alpine Biomed Acquires Stellate Systems 130 8.2 Partnerships 131 8.2.1 MINRAD International Terminates Its Agreement With RxElite 131 8.2.2 Kuros Biosurgery Enters Into An Agreement With Aeris Therapeutics 132 8.2.3 Ingen Technologies Enters Into An Agreement With MacNicol & Associates 133 9 Recent Developments 134 9.1 Strategy And Business Planning 134 9.1.1 Dec 17, 2008: Teleflex Plans To Consolidate Commercial Segment Operations 134 9.1.2 Nov 25, 2008: Minrad Terminates US Distribution Contract With RxElite 134 9.2 Research And Development 135 9.2.1 Sep 02, 2008: Covidien To Buy Building In Mansfield For R&D And Administrative Space 135 9.2.2 Apr 01, 2008: Texas Instruments And IIT Kharagpur To Collaborate On Medical Technology Research 135 9.3 Legal and Regulatory 135 9.3.1 Dec 12, 2008: Terumo And Its Subsidiary Settle Lawsuits With Maquet 135 9.3.2 Oct 10, 2008: I-Flow Will Continue To Enforce Its Patent Rights Against Apex Medical 136 9.3.3 Oct 02, 2008: Cardinal Health Resolve All DEA Claims Related To Controlled Substance 136 9.4 Product News 137 9.4.1 Mar 02, 2009: EarlySense Announces Collaboration With Catholic Healthcare West For Evaluating Patient Health With EverOn 137 9.4.2 Feb 13, 2009: Distribution Agreement Signed Between Teleflex Medical And ResMed Corporation For NIV Mask 137 9.4.3 Feb 12, 2009: Union Springs Pharmaceuticals Unveils Their ViralClyns P95 Disposable Respirator 138 9.4.4 Feb 06, 2009: Masimo Presents New Clinical Study Of Pulse CO-Oximetry At The Society For Critical Care Medicine 138 9.4.5 Feb 02, 2009: Covidien Introduces The New Mallinckrodt SealGuard Evac Endotracheal Tube At The Society Of Critical Care Medicine Congress 139 9.4.6 Feb 02, 2009: Oridion Presents New Study Findings Of Microstream Capnography Technology At STA 139 9.4.7 Jan 29, 2009: CAS Medical Systems Reports FORE-SIGHT Study 140 9.4.8 Jan 27, 2009: Nonin Medical Creates History With The First Continua Certified Product 141 9.4.9 Jan 12, 2009: Asthmatx Submits PMA Seeking FDA Approval For A New Device-Based Procedure To Treat Severe Asthma 141 9.4.10 Dec 23, 2008: Vapotherm Earns A Top Reward For Exhibit At AARC 142 9.4.11 Dec 10, 2008: Oridion Announces Significant Medical Research To Be Presented At AARC Congress 142 9.4.12 Dec 04, 2008: European Respiratory Journal Publishes Results Of Computed Tomography Analysis From Pilot Study Of Spiration`s Novel Emphysema Treatment 143 9.4.13 Dec 03, 2008: Covidien's Hi-Lo Evac Endotracheal Tube Selected For Premier QUEST Comparative Innovation Program 143 9.4.14 Nov 11, 2008: New Study Shows Subglottic Secretions Drainage Reduces Ventilator Associated Pneumonia And Antibiotic Use 144 9.4.15 Nov 05, 2008: Masimo Launches First Non-adhesive Pulse Oximetry Sensor Designed For Extremely Low Birth Weight Babies 144 9.4.16 Oct 24, 2008: Spiration Receives First FDA Approval For Bronchial Valve 145 9.4.17 Oct 23, 2008: New Clinical Studies Presented at the American Society of Anesthesia (ASA) Annual Meeting Show Masimo Technologies Provide Advanced Clinical Intelligence 145 9.4.18 Oct 23, 2008: PARI Respiratory Equipment, Inc. To Present LC PLUS Reusable Nebulizer At CHEST 2008 145 9.4.19 Oct 23, 2008: PARI Respiratory Equipment, Inc. To Present Nebulizer Delivering Budesonide At CHEST 2008 146 9.4.20 Oct 17, 2008: Five New Clinical Studies Show Value Of Masimo PVI & PI 146 10 Appendix 147 10.1 Global Markets Direct Research Methodology 147 10.2 Coverage 148 10.3 Secondary Research 148 10.4 Primary Research 149 10.5 Models 149 10.6 Forecasts 150 10.7 Expert Panel Validation 150 10.8 Currency Conversion 151 10.9 Contact Us 152 10.10 Disclaimer 152 To order this report: Reportlinker Adds North America Anesthesia and Respiratory Devices Investment Opportunities, Analysis and Forecasts to 2015 http://www.reportlinker.com/p0128616/Reportlinker-Adds-North-America-Anesthesia-and-Respiratory-Devices-Investment-Opportunities-Analysis-and-Forecasts-to-2015.html More market research reports here! Reportlinker Nicolas: nbo@reportlinker.com US: (805)-652-2626 Intl: +1 805-652-2626 Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters